USPTO serial 77568457
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Zwijnaarde/Ghent, BE
Zwijnaarde/Ghent, BE
Zwijnaarde/Ghent, BE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark B. Harrison
MARK B. HARRISON VENABLE LLP575 7TH ST NWWASHINGTON, DC 20004-1607UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Compilation and management of computerized databases | SECTION 8 - CANCELLED | — |
| 042 | Scientific services, namely, scientific research and consultation in the field of proteins, peptides and aptamers, and medical research relating thereto; chemistry services, namely, chemistry research and consultation; medical and scientific research services, namely, biological testing services; laboratory services, namely, laboratory research in the field of proteins, peptides and aptamers; scientific testing services in the nature of scientific materials testing; analytical testing in the nature of analytical materials testing; medical and scientific research and consultation services in the field of comparison and quantification of protein and peptide and aptamer profiles; medical and scientific research in the field of screening, validation and verification of biomarkers, candidate biomarkers, genomic biomarkers, proteomic biomarkers and proteins; medical and scientific research and consultation in the field of screening, verification and validation of markers for pathways that are active in protease-related diseases; medical and scientific research and consultation in the field of screening, validation and verification of protease inhibitors and protease activators; medical and scientific research in the field of screening, development, validation and verifications of proteins, peptides and aptamers as biomarkers for protease activity; medical and scientific research and consultation in the field of screening, development, validations and verification of proteins, peptides and aptamers as biomarkers for inhibitions of protease activity; medical and scientific research in the field of antibody-free assay development; medical and scientific research in the field of antibody-free multiplex assay development; medical and scientific research and consultation in the field of biomarker screening, profiling, development, validation and verification, and biomarker candidate screening, validation and verification; medical and scientific research in the field of screening, validation and verification of proteins, peptides and aptamers; medical and scientific research in the field of screening, profiling, development, validation and verification of protein, peptide and aptamer biomarkers; medical and scientific research in the field of biomarker assay identification, development, validation and verification; medical and scientific research in the field of protein biomarker assay development, validation and verification; medical and scientific research in the field of multiplex screening and assays therefor; medical and scientific research in the field of multiplex screening, validation and verification of biomarkers and biomarker candidates; medical and scientific research and consultation in the field of validation and verification of clinical utility and performance of biomarkers and biomarker candidates | SECTION 8 - CANCELLED | — |
| 044 | Medical services; veterinary services; medical testing of proteins, blood and other biological matter; medical profiling in the nature of medical testing and medical diagnostic testing of humans and animals; medical profiling in the nature of medical testing and medical diagnostic testing to predict the response of patients to drugs and side effects; medical profiling in the nature of medical testing and medical diagnostic testing to identify disease progression; provision of medical and veterinary information; medical and veterinary analysis in the nature of medical and veterinary testing and medical and veterinary diagnostic testing for the diagnosis and treatment of persons and animals; provision of medical and veterinary information arising from analysis for the diagnosis and treatment of persons and animals; services for the medical and veterinary testing of blood, cell lysates and other bodily fluids | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 6, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 19, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 14, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 11, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 11, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 11, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 10, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 20, 2009 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 20, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 2, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 2, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 23, 2009 | PAPER RECEIVED | — | |
| Dec 23, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 16, 2008 | NWAP | NEW APPLICATION ENTERED | — |